SEARCH

SEARCH BY CITATION

References

  • APPLEYARD, S.M., CELVER, J., PINEDA, V., KOVOOR, A., WAYMAN, G.A. & CHAVKIN, C. (1999). Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. J. Biol. Chem., 274, 2380223807.
  • APPLEYARD, S.M., PATTERSON, T.A., JIN, W. & CHAVKIN, C. (1997). Agonist-induced phosphorylation of the kappa-opioid receptor. J. Neurochem., 69, 24052412.
  • BENOVIC, J.L., STANISZEWSKI, C., MAYOR JR, F., CARON, M.G. & LEFKOWITZ, R.J. (1988). Beta-adrenergic receptor kinase activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J. Biol. Chem., 263, 38933897.
  • BILSKY, E.J., INTURRISI, C.E., SADEE, W., HRUBY, V.J. & PORRECA, F. (1996). Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain, 68, 229237.
  • BOHN, L.M., GAINETDINOV, R.R., LIN, F.T., LEFKOWITZ, R.J. & CARON, M.G. (2000). Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature, 408, 720723.
  • BOHN, L.M., LEFKOWITZ, R.J. & CARON, M.G. (2002). Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J. Neurosci., 22, 1049410500.
  • CEN, B., YU, Q., GUO, J., WU, Y., LING, K., CHENG, Z., MA, L. & PEI, G. (2001). Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor. J. Neurochem., 76, 18871894.
  • CROCKETT, R.S., BORNSCHEIN, R.L. & SMITH, R.P. (1977). Diurnal variation in response to thermal stimulation: mouse-hotplate test. Physiol. Behav., 18, 193196.
  • DUTTAROY, A. & YOBURN, B.C. (1995). The effect of intrinsic efficacy on opioid tolerance. Anesthesiology, 82, 12261236.
  • ESPEJO, E.F. & MIR, D. (1994). Differential effects of weekly and daily exposure to the hot plate on the rat's behavior. Physiol. Behav., 55, 11571162.
  • FERGUSON, S.S., BARAK, L.S., ZHANG, J. & CARON, M.G. (1996). G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol., 74, 10951110.
  • FINN, A.K. & WHISTLER, J.L. (2001). Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron, 32, 829839.
  • FUNDYTUS, M.E. & CODERRE, T.J. (1999). Opioid tolerance and dependence: a new model highlighting the role of metabotropic glutamate receptors. Pain Forum, 8, 313.
  • GINTZLER, A.R. & CHAKRABARTI, S. (2000). Opioid tolerance and the emergence of new opioid receptor-coupled signaling. Mol. Neurobiol., 21, 2133.
  • GUIGNARD, B., BOSSARD, A.E., COSTE, C., SESSLER D.I. LEBRAULT, C., ALFONSI, P., FLETCHER, D. & CHAUVIN, M. (2000). Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology, 93, 409417.
  • HARRISON, L.M., KASTIN, A.J. & ZADINA, J.E. (1998). Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides, 19, 16031630.
  • HE, L., FONG, J., VON ZASTROW, M. & WHISTLER, J.L. (2002). Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell, 108, 271282.
  • JIN, W., ASSI, A.-A., EASTMAN C TERMAN, G.W. & CHAVKIN, C. (2000). Synaptic plasticity contributes to opioid tolerance in vitro. Soc. Neurosci. Abstr., 26, 636.
  • KEITH, D.E., ANTON, B., MURRAY, S.R., ZAKI, P.A., CHU, P.C., LISSIN, D.V., MONTEILLET-AGIUS, G., STEWART, P.L., EVANS, C.J. & VON ZASTROW, M. (1998). mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol., 53, 377384.
  • KIEFFER, B.L. & EVANS, C.J. (2002). Opioid tolerance–in search of the holy grail. Cell, 108, 587590.
  • KIM, J.A., SIEGEL, S. & PATENALL, V.R. (1999). Drug-onset cues as signals: intraadministration associations and tolerance. J. Exp. Psychol. Anim. Behav. Process, 25, 491504.
  • KISSIN, I., LEE, S.S., ARTHUR, G.R. & BRADLEY JR, E.L. (1996). Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth. Analg., 83, 600605.
  • KOLESNIKOV, Y., JAIN, S., WILSON, R. & PASTERNAK, G.W. (1998). Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect. J. Pharmacol. Exp. Ther., 284, 455459.
  • KOVOOR, A., CELVER, J.P., WU, A. & CHAVKIN, C. (1998). Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol. Pharmacol., 54, 704711.
  • KOVOOR, A., NAPPEY, V., KIEFFER, B.L. & CHAVKIN, C. (1997). Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes. J. Biol. Chem., 272, 2760527611.
  • LEDENT, C., VALVERDE, O., COSSU, G., PETITET, F., AUBERT, J.F., BESLOT, F., BOHME, G.A., IMPERATO, A., PEDRAZZINI, T., ROQUES, B.P., VASSART, G., FRATTA, W. & PARMENTIER, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401404.
  • LI, A.H. & WANG, H.L. (2001). G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J. Neurochem., 77, 435444.
  • LIU, J.G. & ANAND, K.J. (2001). Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res. Brain Res. Rev., 38, 119.
  • LOWE, J.D., CELVER, J.P., GUREVICH, V.V. & CHAVKIN, C. (2002). mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J. Biol. Chem., 277, 1572915735.
  • MAO, J., PRICE, D.D. & MAYER, D.J. (1995). Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain, 62, 259274.
  • MASUKAWA, L.M., O'CONNOR, W.M., BURDETTE, L.J., MCGONIGLE, P., SPERLING, M.R., O'CONNOR, M.J. & URUNO, K. (1997). Mossy fiber reorganization and its possible physiological consequences in the dentate gyrus of epileptic humans. Adv. Neurol., 72, 5368.
  • MAYER, D.J. & MAO, J. (1999). Mechanisms of opioid tolerance: a current view of cellular mechanisms. Pain Forum, 8, 1418.
  • MITCHELL, J.M., BASBAUM, A.I. & FIELDS, H.L. (2000). A locus and mechanism of action for associative morphine tolerance. Nat. Neurosci., 3, 4753.
  • MOGIL, J.S., KEST, B., SADOWSKI, B. & BELKNAP, J.K. (1996). Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J. Pharmacol. Exp. Ther., 276, 532544.
  • MOGIL, J.S., WILSON, S.G., BON, K., LEE, S.E., CHUNG, K., RABER, P., PIEPER, J.O., HAIN, H.S., BELKNAP, J.K., HUBERT, L., ELMER, G.I., CHUNG, J.M. & DEVOR, M. (1999). Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain, 80, 6782.
  • MORRIS, R.G., ANDERSON, E., LYNCH, G.S. & BAUDRY, M. (1986). selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature, 319, 774776.
  • NESTLER, E.J. & AGHAJANIAN, G.K. (1997). Molecular and cellular basis of addiction. Science, 278, 5863.
  • NITSCHE, J.F., SCHULLER A.G KING, M.A., ZENGH, M., PASTERNAK, G.W. & PINTAR, J.E. (2002). Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice. J. Neurosci., 22, 1090610913.
  • PAK, Y., O'DOWD, B.F. & GEORGE, S.R. (1997). Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem., 272, 2496124965.
  • PATEL, M.B., PATEL, C.N., RAJASHEKARA, V. & YOBURN, B.C. (2002). Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo. Mol. Pharmacol., 62, 14641470.
  • PEPPEL, K., BOEKHOFF, I., MCDONALD, P., BREER, H., CARON, M.G. & LEFKOWITZ, RJ. (1997). G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J. Biol. Chem., 272, 2542525428.
  • PITCHER, J.A., FREEDMAN, N.J. & LEFKOWITZ, R.J. (1998). G protein-coupled receptor kinases. Annu. Rev. Biochem., 67, 653692.
  • SIEGEL, S., BAPTISTA, M.A., KIM, J.A., McDONALD, R.V. & WEISE-KELLY, L. (2000). Pavlovian psychopharmacology: the associative basis of tolerance. Exp. Clin. Psychopharmacol., 8, 276293.
  • SIMMONS, M. & CHAVKIN, C. (1996). Endogenous opioid regulation of hippocampal function. In: International Review of Neurobiology, ed. Bradley, R., Harris, A. & Jenner, P. pp. 146149. New York: Academic Press.
  • TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 8587.
  • VANDERAH, T., OSSIPOV, M., LAI, J., MALAN, T.J. & PORECCA, F. (2001). Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain, 92, 59.
  • VARNADO-RHODES, Y., GUNTHER, J., TERMAN, G.W. & CHAVKIN, C. (2000). Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ. Proc. West Pharmacol. Soc., 43, 1517.
  • WHISTLER, J.L., CHUANG, H.H., CHU, P., JAN, L.Y. & VON ZASTROW, M. (1999). Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction [see comments]. Neuron, 23, 737746.
  • YU, Y., ZHANG, L., YIN, X., SUN, H., UHL, G.R. & WANG, J.B. (1997). Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J. Biol. Chem., 272, 2886928874.
  • ZHANG, J., FERGUSON, S.S., BARAK, L.S., ABER M.J GIROS, B., LEFKOWITZ, R.J. & CARON, M.G. (1997). Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arresting in receptor desensitization and resensitization. Receptors Channels, 5, 193199.